Please sign in to follow a disease.
Cassiopea S.p.A.
Clinical trials sponsored by Cassiopea S.p.A., explained in plain language.
A pharmaceutical company focused on dermatology products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New cream could help men regrow hair – phase 3 trial complete
Disease control CompletedThis Phase 3 study tested a topical solution called clascoterone in 703 men with mild to moderate male pattern baldness. Participants applied the solution or a placebo to their scalp twice daily for 6 months, and some continued for another 6 months. The goal was to see if clascot…
Phase 3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cream could help men regrow hair – phase 3 trial complete
Disease control CompletedThis Phase 3 trial tested a topical solution called clascoterone for male pattern hair loss. 762 men with mild to moderate balding applied the solution or a placebo twice daily for 6 months, followed by another 6 months for those who responded. The goal was to see if clascoterone…
Phase 3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC